United Therapeutics Corp (NASDAQ:UTHR)

CAPS Rating: 5 out of 5

A biotechnology company focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases.

Results 1 - 20 of 25 : 1 2 Next »

Recs

1
Member Avatar DrGoldin (99.54) Submitted: 1/2/2016 6:29:12 AM : Outperform Start Price: $154.23 UTHR Score: -16.94

Cup-and-handle formation.

Recs

0
Member Avatar healthcarevalue (97.84) Submitted: 12/6/2015 10:35:16 PM : Outperform Start Price: $158.04 UTHR Score: -14.88

United Therapeutics Corporation (UTHR) - 12.5 price/earnings twelve trailing months, this is lowest price/earnings valuation for this stock going back over two years. Market capitalization 7.25 billion has potential for acquisition. Return on Invested Capital (ROIC) twelve trailing months at impressive 44.99, prior year before that of 24.15. Debt/equity ratio shows negligible to zero long term debt. Focus on treatment of pulmonary arterial hypertension (PAH), an area which will see increased demand in the near future with the demographics of the aging population in the United States.

Recs

0
Member Avatar asilverp (70.37) Submitted: 9/22/2014 12:55:20 AM : Outperform Start Price: $130.14 UTHR Score: -2.79

Headed by Martine Rothblatt, probably one of the more talented people on earth. Overvalued? maybe, but should do ok in the long term.

Recs

0
Member Avatar jsnms (< 20) Submitted: 12/25/2013 12:33:16 AM : Outperform Start Price: $112.56 UTHR Score: +2.72

Recent gap-up with high volume means it will do very well for the next six weeks.

Recs

0
Member Avatar genedom (97.52) Submitted: 9/9/2013 3:50:44 AM : Outperform Start Price: $73.47 UTHR Score: +48.31

Value

Recs

0
Member Avatar manirg (< 20) Submitted: 6/14/2013 1:12:06 PM : Outperform Start Price: $65.40 UTHR Score: +66.05

a good pick for long run

Recs

0
Member Avatar TerryHoodSr (60.21) Submitted: 5/29/2013 2:41:47 PM : Outperform Start Price: $63.78 UTHR Score: +69.60

3yr rev growth 25%
3yr EPS growth 100%

Recs

0
Member Avatar shaileshnita (66.72) Submitted: 4/22/2013 2:09:44 PM : Outperform Start Price: $61.11 UTHR Score: +73.32

It looks cheap.

Recs

0
Member Avatar picbois (98.09) Submitted: 6/24/2012 6:01:01 PM : Outperform Start Price: $47.71 UTHR Score: +105.94

The figures are amazing, many product protected by patent in disease that are not well served for medication.

Recs

1
Member Avatar Calinvestments (97.86) Submitted: 5/13/2011 1:29:33 PM : Outperform Start Price: $66.81 UTHR Score: +36.95

This is a small/mid cap high growth stock that should outperform the S&P during the bull market.

Recs

0
Member Avatar GTROwner (84.65) Submitted: 4/27/2011 11:32:51 PM : Outperform Start Price: $70.38 UTHR Score: +29.52

Will become the dominant player in the PAH market, strong pipeline in multiple high-profit potential orphan diseases like PAH, ILD, PF, Cancer, Stem Cell, and Virology. 30% annual growth over the last 5+ years.

Recs

0
Member Avatar HardnoseDotCom (67.27) Submitted: 4/25/2011 1:31:30 PM : Outperform Start Price: $69.52 UTHR Score: +29.71

low PEG, strong price uptrend

Recs

0
Member Avatar bez780 (< 20) Submitted: 7/29/2009 10:54:21 AM : Outperform Start Price: $42.96 UTHR Score: +81.98

new drugs

Recs

0
Member Avatar LexTNZorro (78.30) Submitted: 5/4/2009 3:21:31 AM : Outperform Start Price: $33.72 UTHR Score: +136.75

http://seekingalpha.com/article/133869-fda-clinical-trial-updates-watson-pharma-united-therapeutics-auxilium-dendreon?source=feed

Recs

0
Member Avatar fanomatic (< 20) Submitted: 4/20/2009 2:44:19 PM : Underperform Start Price: $28.44 UTHR Score: -189.68

This company is limited with products..... and competition for any existing product(s) will happen soon. Its medical device company (Medicomp) is really a small marginally profitable-if at all -firm run by a youngster who was given the job AND isn't a real board certified/practicing MD.
UTHR stock owners should better prepare to SELL now before and when the stock gets to the mid 40's.

Recs

0
Member Avatar wassercom (55.43) Submitted: 2/22/2009 9:15:12 AM : Outperform Start Price: $34.59 UTHR Score: +98.05

Pipeline looks good.

Recs

0
Member Avatar nysegal (66.10) Submitted: 8/5/2008 2:24:22 AM : Outperform Start Price: $55.78 UTHR Score: +58.47

UTHR is a terrific growth stock; accellerating earnings -- 80% in 08 and 68% in 09; recently reported fantastic earnings above street estimates.

Recs

0
Member Avatar ThxUT (< 20) Submitted: 3/13/2008 12:29:05 PM : Outperform Start Price: $39.76 UTHR Score: +147.86

UT leads the market in pulmonary hypertension with rapid growth and a better product than all the competitors.

Recs

0
Member Avatar SteelBreez99 (77.22) Submitted: 12/11/2007 5:47:28 PM : Outperform Start Price: $54.00 UTHR Score: +89.00

VALUE LINES - TIMELY STOCKS IN TIMELY INDUSTRIES

Recs

0
Member Avatar qasamm (24.03) Submitted: 12/11/2007 1:45:24 PM : Outperform Start Price: $53.69 UTHR Score: +91.53

Amazing leadership- many great suprises found in each annual report (no debt, diversity of pipeline, etc.)

Results 1 - 20 of 25 : 1 2 Next »

Featured Broker Partners